An international collaboration led by Flinders University has identified a potential biomarker for amyotrophic lateral sclerosis (ALS), also known as Motor Neuron Disease (MND), providing a […]
Hydroxychloroquine, the anti-malaria drug controversially touted as a cure for COVID despite a lack of robust evidence, is creating renewed interest as a potential treatment for […]
ETH Zurich and the other Swiss universities are committed to reducing the stress and suffering experienced by laboratory animals. However, an outright ban on animal testing—being […]
Multiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there is no definitive cure, is likely caused by infection with […]